نتایج جستجو برای: ctdna

تعداد نتایج: 831  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2017
A R Thierry S El Messaoudi C Mollevi J L Raoul R Guimbaud D Pezet P Artru E Assenat C Borg M Mathonnet C De La Fouchardière O Bouché C Gavoille C Fiess B Auzemery R Meddeb E Lopez-Crapez C Sanchez B Pastor M Ychou

Background While tumor-tissue remains the 'gold standard' for genetic analysis in cancer patients, it is challenged with the advent of circulating cell-free tumor DNA (ctDNA) analysis from blood samples. Here, we broaden our previous study on the clinical validation of plasma DNA in metastatic colorectal cancer patients, by evaluating its clinical utility under standard management care. Patie...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2017
Maria C Schwaederlé Sandip P Patel Hatim Husain Megumi Ikeda Richard B Lanman Kimberly C Banks AmirAli Talasaz Lyudmila Bazhenova Razelle Kurzrock

Purpose: Genomic alterations in blood-derived circulating tumor DNA (ctDNA) from patients with non-small cell lung adenocarcinoma (NSCLC) were ascertained and correlated with clinical characteristics and therapeutic outcomes.Experimental Design: Comprehensive plasma ctDNA testing was performed in 88 consecutive patients; 34 also had tissue next-generation sequencing; 29, other forms of genotypi...

Journal: :Journal of pharmaceutical and biomedical analysis 2014
Shuoye Yang Amer Talbi Xin Wang Hanlin Song Xijing Chen

This study developed a radioisotope detection and tracing method to investigate the pharmacokinetic properties of calf thymus DNA (ctDNA) in rats and beagle dogs. The radioactivity labeling result was detected through gel electrophoresis analysis, and pharmacokinetic analytical methods for (3)H-ctDNA in rat and beagle dog plasma were developed, respectively. Full method validation indicated tha...

Journal: :Nucleic acids research 1981
W A Bovenberg A J Kool H J Nijkamp

A procedure is developed for the isolation of intact chloroplast DNA (ctDNA) from Petunia hybrida. The molecular weight, calculated from contour length measurements, is 96.0 +/- 4.5 x 10(6) daltons. This value is in good agreement with the value of 101.2 x 10(6) daltons that was estimated from the electrophoretic mobilities of restriction endonuclease fragments of ctDNA. Analysis of petunia ctD...

Journal: :Plant physiology 1984
I Kinoshita H Tsuji

Benzyladenine (BA) treatment was found to induce chloroplast DNA (ctDNA) synthesis after it had stopped in primary leaves of light-grown intact bean plants (Phaseolus vulgaris L.). The leaves were treated with BA from 7 days after sowing. Chloroplasts were isolated and the ctDNA content per chloroplast was determined. Chloroplast division occurred until 13 days after sowing in untreated leaves....

2012
Maura Campitelli Emmanuelle Jeannot Martine Peter Emmanuelle Lappartient Stéphanie Saada Anne de la Rochefordière Virginie Fourchotte Séverine Alran Peter Petrow Paul Cottu Jean-Yves Pierga Olivier Lantz Jérôme Couturier Xavier Sastre-Garau

INTRODUCTION In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an emerging marker of tumor dynamics which detection requires specific molecular motif. To determine whether the sequence of the cell-viral junction coul...

2015
Elin S. Gray Helen Rizos Anna L. Reid Suzanah C. Boyd Michelle R. Pereira Johnny Lo Varsha Tembe James Freeman Jenny H.J. Lee Richard A. Scolyer Kelvin Siew Chris Lomma Adam Cooper Muhammad A. Khattak Tarek M. Meniawy Georgina V. Long Matteo S. Carlino Michael Millward Melanie Ziman

Repeat tumor biopsies to study genomic changes during therapy are difficult, invasive and data are confounded by tumoral heterogeneity. The analysis of circulating tumor DNA (ctDNA) can provide a non-invasive approach to assess prognosis and the genetic evolution of tumors in response to therapy. Mutation-specific droplet digital PCR was used to measure plasma concentrations of oncogenic BRAF a...

2017
Jincui Gu Wanchun Zang Bing Liu Lei Li Lixia Huang Shaoli Li Guanhua Rao Yang Yu Yanbin Zhou

Emerging evidence has indicated that circulating tumor DNA (ctDNA) from plasma could be used to analyze EGFR mutation status for NSCLC patients; however, due to the low level of ctDNA in plasma, highly sensitive approaches are required to detect low frequency mutations. In addition, the cutoff for the mutation abundance that can be detected in tumor tissue but cannot be detected in matched ctDN...

2018
C B Thomsen T F Hansen R F Andersen J Lindebjerg L H Jensen A Jakobsen

BACKGROUND Precision medicine calls for an early indicator of treatment efficiency. Circulating tumor DNA (ctDNA) is a promising marker in this setting. Our prospective study explored the association between disease development and change of ctDNA during first line chemotherapy in patients with RAS/RAF mutated metastatic colorectal cancer (mCRC). METHODS The study included 138 patients with m...

2017
Zhangjing Wei Wenyue Wang Zitan Shu Xue Zhou Yanfang Zhang

BACKGROUND Clinical monitoring of EGFR-positive NSCLC patients is important to gauge treatment response. The current study addresses the usage of circulating tumor DNA (ctDNA) as a prognostic marker during treatment of first-generation TKIs. MATERIAL AND METHODS Serial samplings of peripheral blood from 200 EGFR-positive NSCLC patients were taken. Baseline ctDNA quantification was conducted by ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید